Upgrade to SI Premium - Free Trial

Morgan Stanley on Medtronic, Inc. (MDT): 'Positive signs, though slightly soft organic'

August 19, 2025 8:29 AM
Morgan Stanley analyst Patrick Wood reiterated an Overweight rating and $107.00 price target on Medtronic, Inc. (NYSE: MDT).The analyst comments ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments

Next Articles